Top

News Release

Molecular Templates to Present at Three March Investor Conferences

February 28, 2020 at 8:00 AM EST

AUSTIN, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will present a corporate overview at the Cowen & Company 40th Annual Health Care Conference, the Barclays Global Healthcare Conference, and the Oppenheimer 30th Annual Healthcare Conference.

Cowen & Company 40th Annual Health Care Conference
Date:   Monday, March 2
Time:   3:30pm Eastern Time
Webcast:   Click here for webcast
     
Barclays Global Healthcare Conference
Date:   Wednesday, March 11
Time:   4:50pm Eastern Time
     
Oppenheimer & Co. 30th Annual Healthcare Conference
Date:   Wednesday, March 18
Time:   1:00pm Eastern Time

About Molecular Templates  
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:

Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com 
862-204-4006

Source: Molecular Templates, Inc.

molecular.jpg

Source: Molecular Templates, Inc.